IMAGE

Figure 1—figure supplement 4.

ID: ZDB-IMAGE-210218-29
Publication: Fazio et al., 2021 - SATB2 induction of a neural crest mesenchyme-like program drives melanoma invasion and drug resistance
All Figures: Figures for Fazio et al., 2021

Image

Figure Caption

Figure 1—figure supplement 4. SATB2 overexpression does not affect proliferation.

(A) Proliferation rates in primary MCR:EGFP (n = 17) and MCR:SATB2 (n = 16) tumors are not statistically different (unpaired two-tailed t-test,), as determined by PH3 immunohistochemistry. (B) Western blot for SATB2 after DOX-induction in SKMEL2, SKMEL28 and A375 human melanoma cell lines. β-Actin was used as a loading control. The two lower bands in SKMEL2 and SKMEL28 are likely degradation products of SATB2 due to the overexpression. (C) Induction of SATB2 does not affect proliferation rates between parental and transduced cell lines, as determined by CellTiterGLO (NS; not significant).

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Elife